Cambridge Cognition Holdings Plc

Cambridge Cognition Holdings Plc develops and markets computerised cognitive assessment technology and platforms. Based in the UK, its primary aim is to provide digital solutions for accurately assessing brain health across pharmaceutical clinical trials and healthcare settings internationally. Operating within the healthcare technology sector, Cambridge Cognition Holdings PLC focuses on creating precise digital tools for measuring cognitive function. These tools are designed to support the development of new treatments and aid in diagnosing neurological and psychiatric disorders. Add this stock to your eToro watchlist to receive news and updates on the COG.L share price. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.